1. Academic Validation
  2. Manganese(II) EOB-Pyclen Diacetate for Liver-Specific MRI

Manganese(II) EOB-Pyclen Diacetate for Liver-Specific MRI

  • ACS Appl Bio Mater. 2022 Feb 21;5(2):451-458. doi: 10.1021/acsabm.1c01259.
Ryan C Hall 1 Jingcan Qin 1 Victoria Laney 1 Nadia Ayat 1 Zheng-Rong Lu 1
Affiliations

Affiliation

  • 1 Department of Biomedical Engineering, Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106, United States.
Abstract

MRI is increasingly utilized for the diagnosis of liver disease and focal liver lesions. Although liver-targeted gadolinium-based contrast agents (GBCAs) have high efficacy, there continue to be safety concerns regarding release of toxic Gd(III) ions. Herein, Mn(EOB-PC2A) is synthesized as a nongadolinium alternative for liver-specific MRI. Mn(EOB-PC2A) has an r1 relaxivity of 2.8 mM-1 s-1 in Dulbecco's phosphate-buffered saline (DPBS) and 5.9 mM-1 s-1 in saline containing human serum albumin at 1.5 T. It has a strong uptake in hepatocytes with minimal toxicity and demonstrated robust liver-specific enhancement at a dose of 60 μmol/kg. Mn(EOB-PC2A) is a promising liver-specific contrast agent for liver MRI.

Keywords

MRI; contrast agent; liver specific; manganese; molecular imaging.

Figures
Products